August 10, 2026: Compounded peptide injections recalled due to high endotoxin levels - Partnership for Safe Medicines
Compounded peptide injections recalled due to high endotoxin levels; businesses must cease distribution and notify customers.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All businesses involved in the distribution of compounded peptide injections. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate action required.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Dietary-Supplement Labeling (FDA) move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.
What changed
Recall of compounded peptide injections due to safety concerns over high endotoxin levels.
Who it affects
All businesses involved in the distribution of compounded peptide injections.
What you must do
Immediately stop distribution of the affected products and notify customers about the recall.
Deadline
Immediate action required.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- FDA: 12 Herbal Supplements Have Been Recalled - thehealthy.com
- FDA Educational Materials Outline New Dietary Ingredient Notification Process for Supplements - Quality Assurance & Food Safety
- FDA Issues Letter to Industry on DSHEA Disclaimer - WholeFoods Magazine
- IL HB0001: HEMP CANNABINOIDS-MINORS
- Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability